4.7 Article

Neuropsychological endophenotype approach to genome-wide linkage analysis identifies susceptibility loci for ADHD on 2q21.1 and 13q12.11

期刊

AMERICAN JOURNAL OF HUMAN GENETICS
卷 83, 期 1, 页码 99-105

出版社

CELL PRESS
DOI: 10.1016/j.ajhg.2008.06.006

关键词

-

向作者/读者索取更多资源

ADHD linkage findings have not all been consistently replicated, suggesting that other approaches to linkage analysis in ADHD might be necessary, such as the use of (quantitative) endophenotypes (heritable traits associated with an increased risk for ADHD). Genome-wide linkage analyses were performed in the Dutch subsample of the International Multi-Center ADHD Genetics (IMAGE) study comprising 238 DSM-IV combined-type ADHD probands and their 112 affected and 195 nonaffected siblings. Eight candidate neuropsychological ADHD endophenotypes with heritabilities > 0.2 were used as quantitative traits. In addition, an overall component score of neuropsychological functioning was used. A total of 5407 autosomal single-nucleotide polymorphisms (SNPs) were used to run multipoint regression-based linkage analyses. Two significant genome-wide linkage signals were found, one for Motor Timing on chromosome 2q21.1 (LOD score: 3.944) and one for Digit Span on 13q12.11 (LOD score: 3.959). Ten suggestive linkage signals were found (LOD scores > 2) on chromosomes 2p, 2q, 3p, 4q, 8q, 12p, 12q, 14q, and 17q. The suggestive linkage signal for the component score that was found at 2q14.3 (LOD score: 2.878) overlapped with the region significantly linked to Motor Timing. Endophenotype approaches may increase power to detect susceptibility loci in ADHD and possibly in other complex disorders.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Correction Psychology, Clinical

The effects of callous-unemotional traits and aggression subtypes on amygdala activity in response to negative faces (vol 52, pg 476, 2023)

Pascal-M Aggensteiner, Nathalie E. Holz, Boris W. Bottinger, Sarah Baumeister, Sarah Hohmann, Julia E. Werhahn, Jilly Naaijen, Shahrzad Ilbegi, Jeffrey C. Glennon, Pieter J. Hoekstra, Andrea Dietrich, Renee Kleine Deters, Melanie C. Saam, Ulrike M. E. Schulze, David J. Lythgoe, Arjun Sethi, Michael C. Craig, Mathilde Mastroianni, Ilyas Sagar-Ouriaghli, Paramala J. Santosh, Mireia Rosa, Nuria Bargallo, Josefina Castro-Fornieles, Celso Arango, Maria J. Penzol, Jorge Vidal, Barbara Franke, Marcel P. Zwiers, Jan K. Buitelaar, Susanne Walitza, Tobias Banaschewski, Daniel Brandeis

PSYCHOLOGICAL MEDICINE (2023)

Review Psychology, Developmental

The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)

David Coghill, Tobias Banaschewski, Samuele Cortese, Philip Asherson, Daniel Brandeis, Jan Buitelaar, David Daley, Marina Danckaerts, Ralf W. Dittmann, Manfred Doepfner, Maite Ferrin, Chris Hollis, Martin Holtmann, Santosh Paramala, Edmund Sonuga-Barke, Cesar Soutullo, Hans-Christoph Steinhausen, Saskia van der Oord, Ian C. K. Wong, Alessandro Zuddas, Emily Simonoff

Summary: ADHD is a common neurodevelopmental disorder in children and adolescents, and timely interventions are a priority. However, current research reports and reviews on interventions for ADHD often lack consistency and are difficult to interpret. Clinicians need to consider methodological issues and gaps in the evidence when evaluating treatments for ADHD.

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2023)

Article Psychology, Developmental

Internalizing problems before and during the COVID-19 pandemic in independent samples of Dutch children and adolescents with and without pre-existing mental health problems

Karen Fischer, Jacintha M. Tieskens, Michiel A. J. Luijten, Josjan Zijlmans, Hedy A. van Oers, Rowdy de Groot, Daniel van der Doelen, Hanneke van Ewijk, Helen Klip, Rikkert M. van der Lans, Ronald De Meyer, Malindi van der Mheen, Maud M. van Muilekom, I. Hyun Ruisch, Lorynn Teela, Germie van den Berg, Hilgo Bruining, Rachel van der Rijken, Jan Buitelaar, Pieter J. Hoekstra, Ramon Lindauer, Kim J. Oostrom, Wouter Staal, Robert Vermeiren, Ronald Cornet, Lotte Haverman, Meike Bartels, Tinca J. C. Polderman, Arne Popma

Summary: The study aimed to assess internalizing problems before and during the COVID-19 pandemic. The results showed that internalizing problems were higher during the first peak of the pandemic in the general population, but similar or lower levels were observed over the course of the pandemic. Children in the clinical population reported more internalizing symptoms during the pandemic, while parents did not report differences. These findings indicate negative effects of the pandemic on children and adolescents' internalizing problems in both general and clinical populations.

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2023)

Review Psychology, Developmental

A meta-analytic review of the impact of ADHD medications on anxiety and depression in children and adolescents

Annie Bryant, Hope Schlesinger, Athina Sideri, Joni Holmes, Jan Buitelaar, Richard Meiser-Stedman

Summary: This meta-analytic review examined the effects of medications on anxiety and depression symptoms in children and adolescents with ADHD. The study found no significant improvement in symptoms of anxiety or depression with ADHD medication compared to placebo control. The lack of reporting on mental health outcomes in ADHD drug trials for children and adolescents was highlighted, emphasizing the importance of standardized measurement in future trials.

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2023)

Article Psychology, Clinical

Age-related brain deviations and aggression

Nathalie E. Holz, Dorothea L. Floris, Alberto Llera, Pascal M. Aggensteiner, Seyed Mostafa Kia, Thomas Wolfers, Sarah Baumeister, Boris Boettinger, Jeffrey C. Glennon, Pieter J. Hoekstra, Andrea Dietrich, Melanie C. Saam, Ulrike M. E. Schulze, David J. Lythgoe, Steve C. R. Williams, Paramala Santosh, Mireia Rosa-Justicia, Nuria Bargallo, Josefina Castro-Fornieles, Celso Arango, Maria J. Penzol, Susanne Walitza, Andreas Meyer-Lindenberg, Marcel Zwiers, Barbara Franke, Jan Buitelaar, Jilly Naaijen, Daniel Brandeis, Christian Beckmann, Tobias Banaschewski, Andre F. Marquand

Summary: This study aimed to reveal the neurobiological characteristics of disruptive behavior disorders (DBD) by integrating individual deviation patterns from multiple imaging modalities. The results showed that DBD patients exhibited increased age-related deviations in the amygdala, suggesting a possible maturational delay. Furthermore, the study identified neural signatures associated with aggression, including the default mode network (DMN), striatum, and amygdala.

PSYCHOLOGICAL MEDICINE (2023)

Review Psychology, Developmental

Annual Research Review: Perspectives on progress in ADHD science - from characterization to cause

Edmund J. S. Sonuga-Barke, Stephen P. Becker, Sven Bolte, Francisco Xavier Castellanos, Barbara Franke, Jeffrey H. Newcorn, Joel T. Nigg, Luis Augusto Rohde, Emily Simonoff

Summary: The article provides a comprehensive overview of the scientific field of ADHD, covering clinical characteristics, risk factors, causal processes, and neurobiological pathways. The authors also discuss the future of the ADHD construct in light of recent conceptual reformulations.

JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY (2023)

Article Psychology, Developmental

Machine Learning and MRI-based Diagnostic Models for ADHD: Are We There Yet?

Yanli Zhang-James, Ali Shervin Razavi, Martine Hoogman, Barbara Franke, Stephen V. Faraone

Summary: This systematic review examines the literature on the development of magnetic resonance imaging (MRI)-based diagnostic classifiers for attention-deficit/hyperactivity disorder (ADHD) using machine learning (ML). It found variations in MRI modalities, ML models, cross-validation and testing methods, and sample sizes among the studies. The review also highlights the importance of large multi-modal imaging datasets and the potential combination with other types of data to develop clinically useful imaging classification tools for ADHD in the future.

JOURNAL OF ATTENTION DISORDERS (2023)

Article Genetics & Heredity

Multi-polygenic scores in psychiatry: From disorder specific to transdiagnostic perspectives

Yingjie Shi, Emma Sprooten, Peter Mulders, Janna Vrijsen, Janita Bralten, Ditte Demontis, Anders D. Borglum, G. Bragi Walters, Kari Stefansson, Philip van Eijndhoven, Indira Tendolkar, Barbara Franke, Nina Roth Mota

Summary: This study examines the genetic liability for eight major psychiatric disorders using a dimensional framework. The findings show that the genetic predisposition for depression is primarily reflected in the negative valence domain. This study adds evidence to the ongoing discussion about the misalignment between current psychiatric classification and genetic etiology.

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2023)

Article Endocrinology & Metabolism

Association of ADHD symptoms with type 2 diabetes and cardiovascular comorbidities in adults receiving outpatient diabetes care

Ali Zare Dehnavi, Yanli Zhang-James, Dan Draytsel, Ben Carguello, Stephen V. Faraone, Ruth S. Weinstock

Summary: This study found that approximately 49.2% of adults with type 2 diabetes (T2D) met the diagnostic criteria for attention-deficit/hyperactivity disorder (ADHD). However, there was no direct association between these symptoms and cardiovascular diseases or diabetic control. Further research is needed to clarify the relationship between ADHD symptoms, diabetic control, and comorbidities.

JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY (2023)

Article Clinical Neurology

Shared genetic etiology between ADHD, task-related behavioral measures and brain activation during response inhibition in a youth ADHD case-control study

Gulhan Saracaydin, I. Hyun Ruisch, Daan van Rooij, Emma Sprooten, Barbara Franke, Jan K. K. Buitelaar, Andrea Dietrich, Pieter J. J. Hoekstra

Summary: Impaired response inhibition is considered as a potential endophenotype in attention-deficit/hyperactivity disorder (ADHD), and this study explored the relationship between behavioral and neural correlates of response inhibition and polygenic risk scores for ADHD (PRS-ADHD). The findings revealed that PRS-ADHD was associated with ADHD symptom severity, slower and more variable response to stimuli, and altered brain activation during response inhibition. The study suggests a shared genetic etiology of ADHD and response inhibition, emphasizing the importance of genetic liability in ADHD and its impact on attention regulation.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2023)

Article Clinical Neurology

The impact of the COVID-19 pandemic on ADHD medicine consumption in 47 countries and regions

Sophie Gimbach, Daniel Vogel, Roland Fried, Stephen Faraone, Tobias Banaschewski, Jan Buitelaar, Manfred Doepfner, Richard Ammer

Summary: The study aims to measure the impact of the COVID-19 pandemic on global and national consumption of ADHD medication using pharmaceutical sales data from 2014 to 2021 across 47 countries. A SARIMA model was used to predict medication consumption in 2020 and 2021 based on historical data. The findings show that the pandemic resulted in a significant decrease in ADHD medication consumption in 2020, but an increase in consumption in 2021, with a strong correlation to government anti-pandemic policies.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2023)

Correction Biochemistry & Molecular Biology

Association between autism spectrum disorder (ASD) and vision problems. A systematic review and meta-analysis (Jul, 10.1038/s41380-023-02143-7, 2023)

John Perna, Alessio Bellato, Preethi S. Ganapathy, Marco Solmi, Andrea Zampieri, Stephen V. Faraone, Samuele Cortese

MOLECULAR PSYCHIATRY (2023)

Review Pharmacology & Pharmacy

Pediatric attention deficit hyperactivity disorder (ADHD): 2022 updates on pharmacological management

Lisa O'Connor, Stephanie Carbone, Anthony Gobbo, Hilary Gamble, Stephen Faraone

Summary: This article provides an overview of pharmacological treatment options for pediatric attention-deficit disorder (ADHD), including stimulant and non-stimulant medications. It offers detailed information on new medication options, such as anesthetic agents, extended-release forms, and novel adjunctive medications. These additions are beneficial for clinicians in their treatment toolbox.

EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2023)

Meeting Abstract Mathematical & Computational Biology

Regional and circuit heterogeneity of brain abnormalities in psychiatric disorders

Ashlea Segal, Linden Parkes, Kevin Aquino, Andrew Zalesky, Ben J. Harrison, Jeggan Tiego, Murat Yucel, Leah Braganza, Chao Suo, Mark Bellgrove, Alex Fornito, Seyed Mostafa Kia, Thomas Wolfers, Barbara Franke, Martine Hoogman, Christian F. Beckmann, Lars T. Westlye, Ole A. Andreassen, Christopher Davey, Carles Soriano-Mas, Narcis Cardoner, Michael Berk, Sue Cotton, Andre F. Marquand

JOURNAL OF COMPUTATIONAL NEUROSCIENCE (2023)

暂无数据